Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Future perspectives of immunotherapy against ALS].

Rinsho shinkeigaku = Clinical neurology - 1 Nov 2009

Urushitani Makoto

Abstract excerpt

Emerging evidence suggests that misfolded proteins in the various neurodegenerative diseases can be targets for immunotherapy including vaccination antibody therapy. To date, vaccination strategies have been shown to be effective in Alzheimer's disease, Parkinson's disease, Huntington's disease and Prion disease. Interestingly, the subcellular localization of the target proteins varies, including cytosol,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis
Share to Cell Death
Share to Immunization, Passive

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Motor Neurons

Share to Superoxide Dismutase

Share to Superoxide Dismutase-1

Share to Vaccines

Source

Identifiers

PMID: 20030219
DOI: 10.5692/clinicalneurol.49.818

Genes

SOD1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

[Future perspectives of immunotherapy against ALS].PMID 20030219Read ↗

[Implications of successful immunotherapy in ALS model mice].Semantic proximity Read ↗

[Immunotherapy Against Misfolded Proteins in ALS].Semantic proximity Read ↗

Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice.Semantic proximity Read ↗

Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.Semantic proximity Read ↗

Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis.Semantic proximity Read ↗

Therapeutic tools for familial ALS.Semantic proximity Read ↗

Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.Semantic proximity Read ↗

Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosisSemantic proximity Read ↗

Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.